Evoke Pharma, Inc. - Common Shares (EVOK) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2022 to Q3 2024

Type / Class
Equity / Common Shares
Symbol
EVOK on Nasdaq
Shares outstanding
1,582,162
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evoke Pharma, Inc. - Common Shares (EVOK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 16% $101,856 254,639 Nantahala Capital Management, LLC 03 Feb 2025
Bleichroeder LP 10% 0% $63,223 158,058 -81% Bleichroeder LP 24 Mar 2025

Institutional Holders of Evoke Pharma, Inc. - Common Shares (EVOK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 0 $0 -$1,666,576 0
2024 Q2 3,151,890 $1,667,349 -$8,058 $0.53 15
2024 Q1 3,163,387 $1,929,665 +$1,887,966 $0.61 14
2023 Q4 68,358 $71,784 +$862 $1.05 8
2023 Q3 67,152 $92,398 +$10,966 $1.38 8
2023 Q2 59,161 $97,407 -$18,661 $1.65 8
2023 Q1 68,909 $131,117 +$15,392 $1.90 10
2022 Q4 60,635 $161,221 -$3,397 $2.68 9
2022 Q3 62,077 $116,000 -$14,936 $1.87 5
2022 Q2 69,429 $226,000 +$226,000 $3.29 6